120 related articles for article (PubMed ID: 27506315)
1. Transcriptional regulation of the canine carbonyl reductase 1 gene (cbr1) by the specificity protein 1 (Sp1).
Quiñones-Lombraña A; Cheng Q; Ferguson DC; Blanco JG
Gene; 2016 Oct; 592(1):209-214. PubMed ID: 27506315
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
Ferguson DC; Cheng Q; Blanco JG
Drug Metab Dispos; 2015 Jul; 43(7):922-7. PubMed ID: 25918240
[TBL] [Abstract][Full Text] [Related]
3. DNA sequence variants in the carbonyl reductase 1 (cbr1) gene in seven breeds of Canis lupus familiaris.
Cheng Q; Sanborn C; Ferguson D; Blanco JG
Genet Mol Res; 2012 Apr; 11(2):1109-16. PubMed ID: 22614280
[TBL] [Abstract][Full Text] [Related]
4. Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.
Quiñones-Lombraña A; Ferguson D; Hageman Blair R; Kalabus JL; Redzematovic A; Blanco JG
Pharm Res; 2014 Jul; 31(7):1644-55. PubMed ID: 24562808
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2.
Miura T; Taketomi A; Nishinaka T; Terada T
Chem Biol Interact; 2013 Feb; 202(1-3):126-35. PubMed ID: 23247010
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor.
Lakhman SS; Chen X; Gonzalez-Covarrubias V; Schuetz EG; Blanco JG
Mol Pharmacol; 2007 Sep; 72(3):734-43. PubMed ID: 17569794
[TBL] [Abstract][Full Text] [Related]
7. Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.
Kalabus JL; Sanborn CC; Jamil RG; Cheng Q; Blanco JG
Drug Metab Dispos; 2010 Dec; 38(12):2096-9. PubMed ID: 20729274
[TBL] [Abstract][Full Text] [Related]
8. Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1.
Hintzpeter J; Hornung J; Ebert B; Martin HJ; Maser E
Chem Biol Interact; 2015 Jun; 234():162-8. PubMed ID: 25541467
[TBL] [Abstract][Full Text] [Related]
9. A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity.
Gonzalez-Covarrubias V; Ghosh D; Lakhman SS; Pendyala L; Blanco JG
Drug Metab Dispos; 2007 Jun; 35(6):973-80. PubMed ID: 17344335
[TBL] [Abstract][Full Text] [Related]
10. The modulation of carbonyl reductase 1 by polyphenols.
Boušová I; Skálová L; Souček P; Matoušková P
Drug Metab Rev; 2015; 47(4):520-33. PubMed ID: 26415702
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER).
Gonzalez-Covarrubias V; Kalabus JL; Blanco JG
Pharm Res; 2008 Jul; 25(7):1730-4. PubMed ID: 18449627
[TBL] [Abstract][Full Text] [Related]
12. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin.
Seliger JM; Martin HJ; Maser E; Hintzpeter J
Chem Biol Interact; 2019 May; 305():156-162. PubMed ID: 30849340
[TBL] [Abstract][Full Text] [Related]
14. Carbonyl reductase 1 is an essential regulator of skeletal muscle differentiation and regeneration.
Lim S; Shin JY; Jo A; Jyothi KR; Nguyen MN; Choi TG; Kim J; Park JH; Eun YG; Yoon KS; Ha J; Kim SS
Int J Biochem Cell Biol; 2013 Aug; 45(8):1784-93. PubMed ID: 23732109
[TBL] [Abstract][Full Text] [Related]
15. Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia.
Varatharajan S; Abraham A; Zhang W; Shaji RV; Ahmed R; Abraham A; George B; Srivastava A; Chandy M; Mathews V; Balasubramanian P
Eur J Clin Pharmacol; 2012 Dec; 68(12):1577-86. PubMed ID: 22562609
[TBL] [Abstract][Full Text] [Related]
16. Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter.
De Luca A; Sacchetta P; Nieddu M; Di Ilio C; Favaloro B
BMC Mol Biol; 2007 May; 8():39. PubMed ID: 17519015
[TBL] [Abstract][Full Text] [Related]
17. Hyperosmolarity-induced up-regulation of claudin-4 mediated by NADPH oxidase-dependent H2O2 production and Sp1/c-Jun cooperation.
Ikari A; Atomi K; Yamazaki Y; Sakai H; Hayashi H; Yamaguchi M; Sugatani J
Biochim Biophys Acta; 2013 Dec; 1833(12):2617-2627. PubMed ID: 23816505
[TBL] [Abstract][Full Text] [Related]
18. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
[TBL] [Abstract][Full Text] [Related]
19. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
20. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
Huang W; Ding L; Huang Q; Hu H; Liu S; Yang X; Hu X; Dang Y; Shen S; Li J; Ji X; Jiang S; Liu JO; Yu L
Hepatology; 2010 Aug; 52(2):703-14. PubMed ID: 20683966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
